Roche Ebola test gets emergency OK from U.S. regulators

December 29, 2014 9:30 AM

16
0

ZURICH — Roche Holding AG said Monday it has received emergency authorization by U.S. drug regulators for an Ebola virus test, a development that could help health-care authorities around the world fight the current outbreak of the deadly disease.

Basel-based Roche ROG, +0.41% said in a statement that the U.S. Food and Drug Administration had authorized use of its LightMix (R) Ebola Zaire rRT-PCR Test on patients with signs and symptoms of the Ebola virus, and who met other risk factors, such as travel from West Africa, where the current out...